Bright night light exposure increases mortality risk, while daylight reduces it

The use of immune checkpoint inhibitors given as part of an immunosuppressive regimen for kidney transplant recipients with advanced cutaneous cancers may be effective and

Bris­tol My­ers Squib has made a $35 mil­lion in­vest­ment in­to the T cell-fo­cused biotech Im­mat­ics, pur­chas­ing over 2.4 mil­lion shares. The move will al­low for